| Literature DB >> 10579533 |
R L Hanson1, M D Schwinden, A Banerjee, D B Brzozowski, B C Chen, B P Patel, C G McNamee, G A Kodersha, D R Kronenthal, R N Patel, L J Szarka.
Abstract
L-6-Hydroxynorleucine, a key chiral intermediate used for synthesis of a vasopeptidase inhibitor, was prepared in 89% yield and > 99% optical purity by reductive amination of 2-keto-6-hydroxyhexanoic acid using glutamate dehydrogenase from beef liver. In an alternate process, racemic 6-hydroxynorleucine produced by hydrolysis of 5-(4-hydroxybutyl)hydantoin was treated with D-amino acid oxidase to prepare a mixture containing 2-keto-6-hydroxyhexanoic acid and L-6-hydroxynorleucine followed by the reductive amination procedure to convert the mixture entirely to L-6-hydroxynorleucine, with yields of 91 to 97% and optical purities of > 99%.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10579533 DOI: 10.1016/s0968-0896(99)00158-3
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641